<DOC>
	<DOCNO>NCT02124317</DOCNO>
	<brief_summary>The purpose study determine efficacy safety nanoparticle albumin-bound paclitaxel ( nab-paclitaxel ) plus S-1 first-line treatment Chinese patient advance pancreatic ductal adenocarcinoma ( PDA ) .</brief_summary>
	<brief_title>Nab-paclitaxel Plus S-1 Patients With Advanced Pancreatic Cancer</brief_title>
	<detailed_description>Advanced PDA lethal disease approximately 6 month median survival . Gemcitabine always approve single agent . The recent result phase III trial MPACT ( Metastatic Pancreatic Adenocarcinoma Clinical Trial ) demonstrate improvement overall response rate ( ORR ) , progression free survival ( PFS ) overall survival ( OS ) combination nab-paclitaxel plus gemcitabine compare gemcitabine alone . Thus , combination nab-paclitaxel gemcitabine become one standard treatment metastatic PDA . S-1 oral fluoropyrimidine , show non-inferior gemcitabine OS unresectable pancreatic cancer , also demonstrate non-inferior , even superior gemcitabine adjuvant chemotherapy . This single-arm study explore efficacy safety nab-paclitaxel plus S-1 first-line treatment Chinese patient local advance metastatic pancreatic ductal adenocarcinoma .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1 . Signed informedconsent form . 2 . Age le 18 year . 3 . Histologically confirm locally advanced metastatic pancreatic ductal adenocarcinoma , RECIST measurable lesion . 4 . Eastern Cooperative Oncology Group ( ECOG ) 01 life expectation le 12 week . 5 . Patients must receive previous chemotherapy investigational therapy treatment metastatic disease . Prior treatment 5fluorouracil gemcitabine administer radiation sensitizer adjuvant setting allow , provide least 6 month elapse since completion last dose linger toxicity present . 6 . Adequate liver/bone marrow function . 7 . Human Chorionic Gonadotropin ( HCG ) test negative female contraception measure 3 month study end . 8 . Compliant , follow regularly . 1 . Pregnant breastfeed female , willing take contraception measure study . 2 . Serious infection require antibiotic intervention recruitment . 3 . Allergic study drug . 4 . More grade 1 neuropathy . 5 . Uncontrolled brain metastasis mental illness . 6 . Congestive heart failure , uncontrolled cardiac arrhythmia , etc . 7 . Other malignancy within 5 year . 8 . Ca n't follow obey protocol . 9 . Ineligible discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>nanoparticle albumin-bound paclitaxel</keyword>
	<keyword>S-1</keyword>
	<keyword>advanced pancreatic cancer</keyword>
	<keyword>objective response rate</keyword>
</DOC>